Tag: Parkinson's research
Over 200,000 Australians are currently living with Parkinson’s disease, with a further 38 diagnosed everyday. It’s the fastest growing neu...
We are rapidly approaching the end of 2023, a huge year in Parkinson’s research. Thank you to everyone in our community for your steadfast support o...
In this chat with Dr. Fazel Shabanpoor, we hear about his research into antisense oligonucleotides (ASOs), which offer a new therapeutic strategy in P...
In June this year, we shared the first of our regular quarterly progress updates for the Shake It Up Australia Foundation. Since then, we’ve seen ma...
In this chat with Dr. Cedric Bardy, Associate Professor at SAHMRI (South Australia Health and Medical Research Institute) and Flinders University, we ...
In this chat with Associate Professor Miguel Rentería, we hear about the Australian Parkinson’s Genetics Study, and how the study of genes is h...
In December of last year, I took on the role as CEO of Shake It Up Australia, after nearly six years as Executive General Manager. At the time, I shar...
On Saturday, February 11th, we celebrate the International Day of Women and Girls in Science, which was established by the United Nations General Asse...
A new research study being conducted by Abbvie aims to understand how Parkinson’s disease is affecting people living with the condition, their f...
Parkinson’s disease (PD) isn’t the same for every patient. Patients will progress at different rates, or experience certain symptoms that affect t...
The U.S. Food and Drug Administration (FDA) last week approved lecanemab (brand name Leqembi) developed by Eisai Co Ltd. and Biogen Inc. for people w...
Scientists have recently discovered that the skin of people with Parkinson’s disease (PD) has a unique scent. And MJFF-funded scientists are now wo...
Our partners at The Michael J Fox Foundation take a walk down memory lane as we review recent research highlights and milestones in the 20-year histor...
Recent interviews conducted by Shake It Up supporter Maree Faulkner with 21 Australians living with Parkinson’s explored the impact of their diagnos...
Last month, CEO, of The Michael J. Fox Foundation (MJFF), Todd Sherer, PhD, led a panel at the Precision Medicine Leaders Summit called “The Power o...
A study published in the scientific journal Neurology sheds new light on how diabetes affects Parkinson’s disease risk. While the association betw...
Two recent papers outline the progression of Parkinson’s disease (PD) movement or motor symptoms in distinct study populations. While these findings...
Could Parkinson’s disease be an autoimmune disorder? A recent study from Columbia University revealed a possible link between the immune system — ...
Using the same medicine(s) to treat everyone with a given disease is the mainstay of modern medicine. Nonetheless, this “one-size-fits-all” approa...
2017 marks the 200th anniversary of James Parkinson’s description of the disease that now bears his name and that affects an estimated 5 million peo...
Parkinson’s disease (PD) is a complex and varied disorder with many different potential motor and non-motor symptoms. Early on, it can sometimes be ...
Glutathione is made naturally by the body but is also available in certain foods and over-the-counter supplements. Glutathione levels decrease with ag...
Over the past few months, one particular Alzheimer’s disease (AD) drug target has repeatedly been in the news for all the wrong reasons: a protein c...